Medical Affairs Today
The biggest risk for pre-commercial companies is being singularly focused on a lean development program without…
The Right Forum, at the Right Time
Some people need to “think out loud.” Others are eager to get right to the point. Toss in challenging schedules and…
100 Dots Connected: Reflecting on Eight Years of Conversations
The first edition of "Connecting the Dots" was published on September 29, 2017. Since Sue Nemetz penned that inaugural…
Assuming the Role of Patient
As readers of The NemetzGroup newsletter know, we often use this space to consider progress in biopharma, new…
The “Forcing Function” of JPM
Biopharma companies need to balance many critical priorities, especially those that are pre-commercial.
Connecting in a Volatile Job Market
What is the correct metaphor for today’s biopharma job market? A roller-coaster? A crater? A dark cloud? A correction?……
A Practical Guide to Biopharma Year-End Planning
As summer winds down and vacations (sadly) come to an end, it’s a natural time to shift focus toward the close of the…
Building Credibility as a New Leader
Credibility is essential for leaders in any industry, but in the high-stakes world of pharma and biotech, it is even…
BIO and Boston: The Global Stage and HLYB
Attending a large conference, medical congress, or trade show can be both exhausting and exhilarating. The decision to…